Results 81 to 90 of about 105,471 (261)

Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge

Indian Journal of Medical and Paediatric Oncology, 2014
Carboplatin and paclitaxel as doublet are the standard therapeutic option for advanced stage ovarian carcinoma in the first line as well as relapse. Carboplatin with its better toxicity profile has replaced cisplatin as the first line drug.
Avinash Pandey, Bharat Bhosale, Vimal Pandita, Ashish Singh, Joydeep Ghosh, Jaya Ghosh, Jyoti Bajpai   +6 more
doaj   +1 more source

The Association of Increased Spontaneous Lymphocyte Transformation in Vitro with Clinical Manifestations of Drug Hypersensitivity [PDF]

, 1967
Fred A. Gill
openalex   +1 more source

Expert Perspectives on a Clinical Challenge: Hematologic Malignancies and Vasculitis

Arthritis &Rheumatology, Accepted Article.
Systemic vasculitis describes a collection of rare diseases each caused by inflammation of blood vessel walls that can cause severe systemic complications [[3, 4]](#ref‐0003). The pattern of vascular inflammation and resultant damage is frequently variable and may be mimicked, or directly triggered, by infection or malignancy.
Michelle L. Robinette, Hetty E. Carraway
wiley   +1 more source

Cutaneous drug hypersensitivity : Immunological and genetic perspective

Indian Journal of Dermatology, 2011
Drug hypersensitivity is an unpredictable, immunologically mediated adverse reaction, clustered in a genetically predisposed individual. The role of "hapten concept" in immune sensitization has recently been contested by the "pharmacological interaction"
Kisalay Ghosh, Gautam Banerjee, Asok Kumar Ghosal, Jayoti Nandi   +3 more
doaj   +1 more source

Impact of Interleukin‐1 Blockade on the Development of Macrophage Activation Syndrome in Still's Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria

Arthritis &Rheumatology, Accepted Article.
Objective To evaluate the applicability of the 2016 EULAR/ACR/PRINTO macrophage activation syndrome (MAS) classification criteria in patients with Still's disease (sJIA‐SD) treated with IL‐1‐targeted therapy and to assess the incidence of MAS in this context.
Remco G.A. Erkens, Greta Rogani, Laura Huber, Anouk Verwoerd, Dieneke Schonenberg‐Meinema, J. Merlijn van den Berg, Wineke Armbrust, G. Elizabeth Legger, Sylvia Kamphuis, Ellen J.H. Schatorjé, Esther P.A.H. Hoppenreijs, Joost F. Swart, Marc H.A. Jansen, Jorg van Loosdregt, Sebastiaan J. Vastert   +14 more
wiley   +1 more source

Hypersensitivity to Antituberculous Drugs [PDF]

, 1964
J. H. Mitchell
openalex   +1 more source

Factors Controlling Diastereoselectivity and Reactivity in the Catalytic Aerobic Carbooxygenation of (E)‐2‐Fluoro‐3‐aryl‐allyl Nitroacetates

Chemistry – An Asian Journal, EarlyView.
Experimental and computational methods reveal unique diastereoconvergency in radical‐based catalytic aerobic carbooxygenation of 2‐fluoro‐3‐aryl‐allyl nitroacetates. Both (E)‐ and (Z)‐isomers are converted into α,α,β,β‐tetrasubstituted γ‐lactones with high syn‐selectivity, even without E/Z isomerization of the alkene unit.
Yanzong Lyu, Florian Pünner, Mai Akakabe, Yoshihiro Sohtome, Mikiko Sodeoka   +4 more
wiley   +1 more source

Adverse events associated with monoclonal antibodies used for treatment of COVID‐19: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, Volume 91, Issue 5, Page 1306-1321, May 2025.
Aims This review aimed to synthesise the evidence related to the incidence of serious and non‐serious adverse events with the use of monoclonal antibodies (mAbs) among COVID‐19 patients. Methods Databases were searched from January 2020 to September 2023 for randomized clinical trials (RCTs) that used mAbs for the treatment of COVID‐19 regardless of ...
Htet Htet, Han You Kyung, Ismail Abdul Sattar Burud, Heethal Jaiprakash, Thiruselvi Subramaniam, Igor Iezhitsa, Renu Agarwal   +6 more
wiley   +1 more source

Editorial: Women in NK and innate lymphoid cell biology

Frontiers in Immunology, 2023
Alessandra Zingoni, Teresa Bellón
doaj   +1 more source

Safety of sulfamethoxazole–trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta‐analysis with active comparator disproportionality analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Sulfamethoxazole–trimethoprim (SMX‐TMP) is a widely used antibiotic for treating bacterial infections, but its safety in adult outpatients remains understudied. This systematic review and meta‐analysis evaluated the safety profile of SMX‐TMP and identified critical research gaps.
Rebecca Preyra, Lujain Ez Eddin, Fatemeh Ahmadi, Atefeh Jafari, Flory T. Muanda   +4 more
wiley   +1 more source